Event | Preoperative setting (3 to 14 days pre-op) | Day of surgery | POD 1 | POD 2 | POD 3 | POD 5 | POD8/discharge day | POD 14 | POD 30 | POD 90 | 6 months post-op | 1 year post-op | 2 years post-op/time of death |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Eligibility screening | X | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Informed consent | X | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Baseline characteristics | X | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Arm allocation | X | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
QoL questionnaire (EQ-5D-5 L) | X |  |  |  |  |  | X | X | X | X | X | X |  |
Intraoperative outcomes | Â | X | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Postoperative outcomes/secondary endpoints | Â | Â | X | X | X | X | X | X | X | X | Â | Â | Â |
Primary endpoint assessment | Â | Â | Â | Â | Â | Â | X | Â | Â | X | Â | Â | Â |
Recurrence-free and overall survival assessment | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | X |